2017
DOI: 10.1111/opo.12425
|View full text |Cite
|
Sign up to set email alerts
|

Retinal putative glial alterations: implication for glaucoma care

Abstract: PurposeGliosis‐like retinal alterations, presumed to be activated retinal astrocytes and Müller cells (ARAM), have been reported to occur frequently in patients with glaucoma but rarely in controls. We investigated the association between glaucomatous abnormality and the presence, the extent of retinal region, and the spatial distribution, of hyperreflective retinal alterations on optical coherence tomography (OCT) en‐face images, presumed to be ARAM.MethodsFindings of hyperreflective structures, presumed to b… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

1
38
0

Year Published

2018
2018
2023
2023

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(39 citation statements)
references
References 18 publications
1
38
0
Order By: Relevance
“…7 Nutzi et al concluded there was no effect of age in a group of 12 patients with an average age of 77.6 AE 7.2 years. 17 In agreement with Ashimatey et al, 8 the present study found a significant age effect. Additionally, ARAM was noted in healthy age-similar controls at similar frequencies to patients with glaucoma.…”
Section: Discussionsupporting
confidence: 93%
See 2 more Smart Citations
“…7 Nutzi et al concluded there was no effect of age in a group of 12 patients with an average age of 77.6 AE 7.2 years. 17 In agreement with Ashimatey et al, 8 the present study found a significant age effect. Additionally, ARAM was noted in healthy age-similar controls at similar frequencies to patients with glaucoma.…”
Section: Discussionsupporting
confidence: 93%
“…• Higher density of ARAM in an eye may be a clinical and structural sign for more advanced glaucoma • ARAM was found in 55% of older controls but not in younger controls, showing an age effect • ARAM was found in 73% of patients with glaucoma • Patients with glaucoma tend to have larger retinal areas with ARAM • Extent of ARAM and its distribution was not predictive of retinal hemifield with the most damage • ARAM was found in 15% to 16% of healthy controls • ARAM was found in 15% to 23% of patients • ARAM was found in 17% to 19% of age-similar sex-matched healthy controls • ARAM was found to be related to age as well as posterior vitreous detachment • ARAM was not found to be related to sex continuous variable such as quantifying the percentage area covered by ARAM may be more helpful, as it has previously been identified as a potential biomarker for retinal ganglion cell (RGC) health 15 and the severity of glaucomatous damage. 8,17 To resolve the relationship of ARAM to glaucoma, and especially to the severity of glaucoma, including subjects with more advanced glaucomatous disease would be informative.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In older individuals and glaucoma patients, hyperreflective structures (activated retinal astrocytes and Müller cells) seen on OCT en face imaging (cpRNFL) are common, whereas these structures are scarce in younger individuals. 34 Also, in primary open-angle glaucoma, these hyperreflective structures have been more frequently identified in eyes showing lower retinal sensitivity and cpRNFL thickness. 35 In our younger subjects, photopic CS showed significant correlation with the thickness measurements of peripheral macular IRL, GCC and cpRNFL (Table 2).…”
Section: Discussionmentioning
confidence: 99%
“…Glaucoma is a multifactorial neurodegenerative disorder and one of the leading causes of irreversible blindness worldwide [1]. While this condition is primarily characterised by the loss of retinal ganglion cells (RGCs) and the gradual degeneration of RGC axons in the optic nerve [2], recent morphological and functional studies have suggested the involvement of other retinal cell types, including atrophic changes in the photoreceptor layer and microglia activation [3][4][5]. At present, intraocular pressure (IOP) is the major clinically modifiable risk factor for glaucoma progression (vision loss) and current therapies seek to modulate IOP via reducing aqueous production or increasing outflow [6].…”
Section: Introductionmentioning
confidence: 99%